InDevR Launches Expert Services to Address Vaccine Development Challenges
InDevR Inc., a global leader in vaccine analytical tools and method development, is excited to announce the launch of its latest offering, Expert Services. Expert...
Eyam Announces Artificial Intelligence Research Facility in Partnership with Mitacs
VANCOUVER, BC / ACCESSWIRE / May 31, 2023 / Eyam announces today the opening of a new research facility in partnership with Mitacs, a national...
Moderna Announces Clinical and Program Updates at 4th Vaccines Day
Next-generation, refrigerator-stable COVID-19 vaccine candidate, mRNA-1283, has dosed first participant in its Phase 3 trialCompany expects to file for approval of its investigational RSV vaccine...
Gemina Laboratories to Host Investor Webinar on March 30, 2023
VANCOUVER, BC / ACCESSWIRE / March 27, 2023 / Gemina Laboratories Ltd. (CSE:GLAB)(FRA:8I7) (the "Company" or "Gemina") is pleased to announce that it will host...
Respiratory Infections the Immediate Focus and New Strategic Partnerships on the Horizon
VANCOUVER, BC / ACCESSWIRE / January 10, 2023 / Gemina Laboratories Ltd. (CSE:GLAB)(FRA:8I7) (the "Company" or "Gemina") is pleased to provide the following strategic overview...
Gemina Labs Completes Influenza A/B Diagnostic Test Prototype
VANCOUVER, BC / ACCESSWIRE / January 6, 2023 / Gemina Laboratories Ltd. (CSE:GLAB)(FRA:8I7) (the "Company" or "Gemina") is pleased to announce the completion of its...